The Institutional Biosafety
Committee (IBC) insures that research involving
recombinant DNA and Biological Materials follow designated guidelines.
The IBC
follows the guidelines established by the National Institutes
of Health (NIH) Office
of Biotechnology Activities and the Center for Disease Control
(CDC).
Institutional
Biosafety Committee Meeting
August
18, 2008
October 20, 2008
December 15, 2008
January 26, 2009
March 16, 2009
May 18, 2009